Q3 2023

Filed Nov 8, 2023 · 10-Q · 39 days after period end · 0001437749-23-030938

Q3 2023 · 10-Q

Revenue

$357.00K

+68.4% vs Q3 2022

Net Income

-$2.57M

N/M vs Q3 2022

EPS, diluted—

Operating Income-$2,598,000N/M

Operating Cash Flowderived-$2,412,000N/M

Same quarter

Metric	Q3 2023	Q3 2022	Q3 2021	Q3 2020
Revenue	$357.00K	$212.00K	$821.00K	$34.00K
Net Income	-$2.57M	-$3.06M	-$2.71M	-$3.85M
EPS Diluted	—	—	-$0.16	-$0.30

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR

BCDABioCardia, Inc.